Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure

Mechanisms and Clinical Applications: A Machine-Generated Literature Overview de

Éditeur :

Springer


Paru le : 2024-11-15

eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
163,35

Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

The book delves into the development and therapeutic potential of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for the treatment of diabetes and cardiovascular diseases. It explores their mechanism of action, cardiovascular benefits, and role in primary and secondary protection from renal and cardiovascular diseases. The book also highlights their emerging opportunities in the management of myocardial infarction, diabetic cardiomyopathy, and congestive heart failure. It provides a comprehensive review of preclinical and clinical information on the cardiovascular advantages of SGLT2 inhibitors. Additionally, the book explores selective drugs and their effects on cardiovascular events, mortality, and safety outcomes in individuals with type 2 diabetes.
The book is a valuable resource for researchers, healthcare professionals, and individuals interested in the field of SGLT2 inhibitors and their impact on diabetes and cardiovascular health.
Pages
528 pages
Collection
n.c
Parution
2024-11-15
Marque
Springer
EAN papier
9789819775675
EAN PDF
9789819775682

Informations sur l'ebook
Nombre pages copiables
5
Nombre pages imprimables
52
Taille du fichier
8479 Ko
Prix
163,35 €
EAN EPUB
9789819775682

Informations sur l'ebook
Nombre pages copiables
5
Nombre pages imprimables
52
Taille du fichier
5233 Ko
Prix
163,35 €

Suggestions personnalisées